Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Clinical Trial Assessing the Effect of "Optimal" Cerebral Perfusion Pressure Monitoring in the Management of Severe Traumatic Brain Injury

NCT02982122 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT02982122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02982122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Clinical Trial Assessing the Effect of "Optimal" Cerebral Perfusion Pressure Monitoring in the Management of Severe Traumatic Brain Injury
Lead sponsor
Maastricht University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2018
Completion date
February 27, 2020
Enrollment
60 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brain injuries, traumatic, cerebrovascular circulation, homeostasis